A Nicotinamide Phosphoribosyltransferase Inhibitor, FK866, Suppresses the Growth of Anaplastic Meningiomas and Inhibits Immune Checkpoint Expression by Regulating STAT1

Anaplastic meningioma is classified as a World Health Organization (WHO) grade III tumor and shows a strong tendency to recur. Although the incidence of anaplastic meningioma is low, the high rate of recurrence and death still makes treatment a challenge. A proteomics analysis was performed to inves...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Yuxuan Deng, Boyi Hu, Yazhou Miao, Jing Wang, Shaodong Zhang, Hong Wan, Zhen Wu, Yifan Lv, Jie Feng, Nan Ji, Deric Park, Shuyu Hao
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2022-04-01
Saila:	Frontiers in Oncology
Gaiak:	anaplastic meningioma NAMPT NAMPT inhibitor immune checkpoint cell cycle proteomics
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fonc.2022.836257/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!